Data dictionary: Melanoom - DMTR: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forresearchers</span> | |||
<span style="display:none">thenetherlandscountry</span> | |||
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | ||
| Line 29: | Line 30: | ||
| Patient Type | | Patient Type | ||
|- | |- | ||
| Location of Primary | | Location of Primary Tumour | ||
|- | |- | ||
| Pathology (PA) Result Known? | | Pathology (PA) Result Known? | ||
| Line 38: | Line 39: | ||
|} | |} | ||
'''Table 3:''' | '''Table 3:''' Tumour Characteristics and Diagnosis. | ||
{| class="wikitable" | {| class="wikitable" | ||
! Variables | ! Variables | ||
| Line 64: | Line 65: | ||
| Distant Metastases | | Distant Metastases | ||
|- | |- | ||
| Locations of Current | | Locations of Current Tumour Presentation | ||
|} | |} | ||
| Line 133: | Line 134: | ||
| Metastases Staging? | | Metastases Staging? | ||
|- | |- | ||
| | | Tumour Stage Before (Neo)adjuvant Treatment | ||
|- | |- | ||
| Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain | | Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain | ||
| Line 139: | Line 140: | ||
| Lab Tests: S100, LDH Levels | | Lab Tests: S100, LDH Levels | ||
|- | |- | ||
| Locations of Current | | Locations of Current Tumour Presentation Metastases Confirmed? | ||
|- | |- | ||
| In-transit Metastases and/or Satellitosis | | In-transit Metastases and/or Satellitosis | ||
| Line 150: | Line 151: | ||
! Variables | ! Variables | ||
|- | |- | ||
| Histology of Primary | | Histology of Primary Tumour Examined | ||
|- | |- | ||
| Revision Histology of Primary | | Revision Histology of Primary Tumour | ||
|- | |- | ||
| Histology and/or Cytology of Current | | Histology and/or Cytology of Current Tumour Presentation Available | ||
|- | |- | ||
| Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined | | Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined | ||
Latest revision as of 17:43, 4 December 2025
Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.
This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.
Table 1: Basic Patient Information.
| Variables |
|---|
| Healthcare Facility |
| Unique Patient Number |
| Date of Birth |
| Gender |
| Date of Death (if applicable) |
Table 2: Melanoma Center Details.
| Variables |
|---|
| Hospital Patient Number |
| Date of First Disease Presentation Diagnosis of Melanoma |
| Patient Type |
| Location of Primary Tumour |
| Pathology (PA) Result Known? |
| PA Number (TJJ-CCCCCC) |
| PA Laboratory |
Table 3: Tumour Characteristics and Diagnosis.
| Variables |
|---|
| Type of Eye Melanoma |
| Type of Melanoma |
| Breslow Thickness in Millimeters (unknown = 999) |
| Ulceration |
| Satellite / In-transit Metastasis |
| Sentinel Node Procedure Performed at Primary Diagnosis? |
| Capsule Rupture Occurrence? |
| Sentinel Node Diameter |
| Primary Melanoma Regression? |
| Lymph Node Metastases (macroscopic) |
| Distant Metastases |
| Locations of Current Tumour Presentation |
Table 4: Comorbidities.
| Variables |
|---|
| Cardiac |
| Vascular |
| Diabetes |
| Pulmonary |
| Neurological/Psychiatric |
| Gastrointestinal |
| Urogenital |
| Thrombotic |
| Musculoskeletal |
| Endocrine Disorders |
| Infectious Diseases |
| Malignancy |
| Autoimmune Disorders |
| Organ Transplantation |
| Other Comorbidities |
Table 5: Medications Usage.
| Variables |
|---|
| Analgesics: Start and Stop Dates, Reason for Use |
| Antibiotics: Start and Stop Dates, Reason for Use |
| Antiviral Agents: Start and Stop Dates, Reason for Use |
| Anticoagulants and Thrombolytics: Start and Stop Dates, Reason for Use |
| Anticonvulsants: Start and Stop Dates, Reason for Use |
| Antiemetics: Start and Stop Dates, Reason for Use |
| Anti-inflammatory Drugs: Start and Stop Dates, Reason for Use |
| Corticosteroids: Start and Stop Dates, Reason for Use |
| Imuran (Azathioprine): Start and Stop Dates, Reason for Use |
| Interferon: Start and Stop Dates, Reason for Use |
Table 6: Metastases and Staging.
| Variables |
|---|
| Metastases Staging? |
| Tumour Stage Before (Neo)adjuvant Treatment |
| Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain |
| Lab Tests: S100, LDH Levels |
| Locations of Current Tumour Presentation Metastases Confirmed? |
| In-transit Metastases and/or Satellitosis |
| Recurrent Primary Melanoma |
Table 7: Histology and Genetics.
| Variables |
|---|
| Histology of Primary Tumour Examined |
| Revision Histology of Primary Tumour |
| Histology and/or Cytology of Current Tumour Presentation Available |
| Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined |
| Other Detected Genmutations |